These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8740200)

  • 21. Somatostatin and diabetes: suppression of glucose absorption rather than stimulation of glucose disposal.
    Felig P; Wahren J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1509-10. PubMed ID: 979657
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatostatin. Total solid phase synthesis.
    Rivier JE
    J Am Chem Soc; 1974 May; 96(9):2986-92. PubMed ID: 4598650
    [No Abstract]   [Full Text] [Related]  

  • 23. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
    Valcavi R; Zini M
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment].
    Lunetta M; Di Mauro M; Le Moli R
    Minerva Endocrinol; 1992; 17(1):7-12. PubMed ID: 1495454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous subcutaneous octreotide infusion: dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (type 1) diabetes.
    Osei K; O'Dorisio TM; Malarkey WB; Cataland S
    J Lab Clin Med; 1991 Jul; 118(1):56-64. PubMed ID: 2066644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus.
    Martina V; Miola C; Maccario M; Talliano M; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1992 Nov; 24(11):520-3. PubMed ID: 1333441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone-releasing hormone (GHRH)].
    Shintani Y; Saito S
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():342-5. PubMed ID: 8753250
    [No Abstract]   [Full Text] [Related]  

  • 29. The attenuated inhibitory action of octreotide, a somatostatin analogue on GHRH-induced growth hormone response in type I diabetes mellitus.
    Krassowski J; Rogala H; Jeske W; Zgliczynski S
    Horm Metab Res; 1996 Apr; 28(4):207-8. PubMed ID: 8740200
    [No Abstract]   [Full Text] [Related]  

  • 30. [Analgesic effects of natural growth hormone release inhibitors and their synthetic analogs. Intraspinal administration].
    Beltrutti D; Debernardi F; Pelosi G
    Minerva Med; 1997; 88(1-2):39-47. PubMed ID: 9132630
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.